China SXT Pharmaceuticals Inc (SXTC) — Financial Flexibility Index
China SXT Pharmaceuticals Inc (SXTC) has a Financial Flexibility Index of -0.45x as of June 2026. Free cash flow of $-2.26 Million (operating CF $-2.26 Million minus capex $0.00) represents 0% of total liabilities ($5.05 Million). Check asset allocation strategy of China SXT Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China SXT Pharmaceuticals Inc Financial Flexibility Index (2016–2026)
Historical Financial Flexibility Index trend for China SXT Pharmaceuticals Inc across 11 annual periods. See China SXT Pharmaceuticals Inc (SXTC) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for China SXT Pharmaceuticals Inc (2016–2026)
Year-by-year free cash flow to debt coverage for China SXT Pharmaceuticals Inc. For the full company profile including market capitalisation, see China SXT Pharmaceuticals Inc (SXTC) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -0.80x | $-4.02 Million | $-4.02 Million | $5.05 Million | ▼ -111.4% |
| 2025 | -0.38x | $-2.34 Million | $-2.35 Million | $6.22 Million | ▼ -80.3% |
| 2024 | -0.21x | $-1.92 Million | $-1.93 Million | $9.20 Million | ▼ -30720.4% |
| 2023 | 0.00x | $-10.07K | $-80.76K | $14.86 Million | ▼ -103.5% |
| 2022 | 0.02x | $330.78K | $268.29K | $17.12 Million | ▲ +129.3% |
| 2021 | -0.07x | $-1.22 Million | $-1.32 Million | $18.59 Million | ▼ -160.4% |
| 2020 | 0.11x | $1.34 Million | $934.25K | $12.30 Million | ▼ -18.3% |
| 2019 | 0.13x | $849.28K | $239.19K | $6.36 Million | ▼ -80.4% |
| 2018 | 0.68x | $2.97 Million | $1.92 Million | $4.37 Million | ▲ +407.3% |
| 2017 | 0.13x | $479.35K | $293.04K | $3.58 Million | ▲ +166.2% |
| 2016 | 0.05x | $279.46K | $182.47K | $5.55 Million | — |